STI(300416)
Search documents
苏试试验(300416) - 2016年4月28日投资者关系活动记录表
2022-12-06 09:01
证券代码:300416 证券简称:苏试试验 苏州苏试试验仪器股份有限公司 投资者关系活动记录表 编号:2016-006 | --- | --- | --- | |--------------|----------------------------|-------------------------------------------------------------------------------------------------------------------| | | | | | | □ | 特定对象调研 □分析师会议 | | | □媒体采访 | □业绩说明会 | | 投资者关系活 | □ 新闻发布会 □路演活动 | | | 动类别 | □现场参观 | | | | 其他 | (深交所在公司举办"践行中国梦·走进上市公司" 投 | | | 资者开放日) | | | | 1 | 、通过东吴证券、东方证券、上海证券、中信证券、海通证券、 银河证券、兴业证券、华泰证券、英大证券、九州证券、国元证 | | 投资者单位名 | | 券、中原证券、财达证券、安信证券、湘财证券、申万宏源证券、 | | | | ...
苏试试验(300416) - 2016年4月19日投资者关系活动记录表
2022-12-06 08:56
证券代码:300416 证券简称:苏试试验 苏州苏试试验仪器股份有限公司 投资者关系活动记录表 编号:2016-005 | --- | --- | --- | |---------------------------|-------------------------|-----------------------------------------------------------| | | | 特定对象调研 □分析师会议 | | 投资者关系活 | □ | 媒体采访 □业绩说明会 | | 动类别 | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | □ 其他 | (请文字说明其他活动内容) | | 投资者单位名 称及人员姓名 | 中金公司 | 史成波、雍岳、余旻琦 工银瑞信 何肖颉、修世宇、王君正 | | | | | | 时间 | 2016 年 4 月 19 | 日 | | 地点 | 公司二楼会议室 | | | 上市公司 接待人员姓名 | 钟琼华、陈英、骆星烁 | | | 投资者关系活 | 1 | 、公司转型比较成功,去年服务业收入已突破 1 亿,主要原 | | 动主要内容介 | ...
苏试试验(300416) - 2016年11月10日投资者关系活动记录表
2022-12-06 01:46
Group 1: Company Overview - Suzhou Su Shi Testing Instrument Co., Ltd. primarily serves military and civilian clients, with both segments growing in recent years [2] - The company’s testing equipment was initially focused on military enterprises, but the share of civilian clients has been increasing due to higher quality demands [2] Group 2: Testing Services and Standards - The company’s testing services are not mandatory but are subject to high industry standards in sectors like military and high-speed rail [3] - Automotive companies have their own testing standards, indicating a diverse range of client requirements [3] Group 3: Capital Increase and Development - The capital increase projects are aligned with the company’s core business, focusing on expanding testing equipment from mechanical to climate environments and enhancing comprehensive service offerings [3] - The capital increase aims to accelerate the company’s development process [3] Group 4: Client Base and Service Growth - The client base for testing equipment and services largely overlaps, with national laboratories served regionally [3] - Service growth is driven by expanding testing capabilities, increasing laboratory scale, and adding more laboratory locations [4] Group 5: Equipment and Profitability - The selling price of testing equipment has remained stable, but gross profit margins have declined due to rising costs [4] - The company’s new integrated testing system ensures precise consistency in meeting customer demands [4] Group 6: Personnel and Training - Different positions in testing require varying qualifications, with the company providing comprehensive training from experienced experts [4] - Vibration testing equipment is primarily used during the product development phase, with sampling tests conducted post-finalization [4]
苏试试验(300416) - 2017年9月6日投资者关系活动记录表
2022-12-05 01:16
证券代码:300416 证券简称:苏试试验 苏州苏试试验集团股份有限公司 投资者关系活动记录表 编号:2017-001 | --- | --- | --- | |-----------------------|-----------------------------|------------------------------------------------------| | | | | | | | 特定对象调研 □分析师会议 | | 投资者关系活 | □ | 媒体采访 □业绩说明会 | | 动类别 | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | □ 其他 | (请文字说明其他活动内容) | | | 安信证券 | 余平、张超 国信证券 李君海 | | | | 玖石投资 郭晓玮 以舟投资 邓天坤 | | 投资者单位名 | 昆仑资产 王 浩 | 沃田资产 杨安明 | | 称及人员姓名 | 东兴证券 王光清 富春投资 | 徐 再 | | | | 中国银河 张义慧 创东方投资 刘 伟 | | | 正和资本 程 兵 | 方正富邦基金 关 旭 | | | | 中国平安 邢 振 俾斯曼资 ...
苏试试验(300416) - 苏试试验调研活动信息
2022-12-04 09:02
证券代码:300416 证券简称:苏试试验 1 苏州苏试试验集团股份有限公司 投资者关系活动记录表 编号:2019-003 | --- | --- | --- | |-----------------------|----------------------------------------|----------------------------------------------------------| | | | | | | | 特定对象调研 分析师会议 | | | 媒体采访 | 业绩说明会 | | 投资者关系活动 | 新闻发布会 路演活动 | | | 类别 | 现场参观 | | | | 其他 | (请文字说明其他活动内容) | | | 东北证券 | 刘军、朱宇航 | | 投资者单位名称 | 国海证券 邹刚 | | | | 亘曦资产 董高峰 | | | 及人员姓名 | 爱建证券 章孝林 | | | | | | | 时间 | 浙商证券 闻茗萱 | | | | 2019 年 10 月 30 | 日 | | 地点 | 公司二楼会议室 | | | 上市公司 接待人员姓名 | 副总经理兼董事会秘书 陈英 证券 ...
苏试试验(300416) - 苏试试验调研活动信息
2022-12-04 08:58
证券代码:300416 证券简称:苏试试验 苏州苏试试验集团股份有限公司 投资者关系活动记录表 编号:2019-002 | --- | --- | --- | |----------------|---------------------------------------|----------------------------| | | | | | | | 特定对象调研 分析师会议 | | | 媒体采访 | 业绩说明会 | | 投资者关系活动 | 新闻发布会 路演活动 | | | 类别 | 现场参观 | | | | 其他 | (请文字说明其他活动内容) | | | 中信保诚基金 | 郑伟 | | | 国泰基金 高亮 | | | 投资者单位名称 | 上海汐泰投资 | 何亚东 | | 及人员姓名 | 长城基金 周诗博 汇添富基金 董超 | | | | 亘曦资产 蔡麟琳 | | | 时间 | 2019 年 10 月 29 | 日 | | 地点 | 公司二楼会议室 | | | 上市公司 | 董事长兼总经理 副总经理兼董事会秘书 | 钟琼华 陈英 | | 接待人员姓名 | 证券事务代表 骆星烁 | | 1 | -- ...
苏试试验(300416) - 苏试试验调研活动信息
2022-12-03 10:30
证券代码:300416 证券简称:苏试试验 苏州苏试试验集团股份有限公司 投资者关系活动记录表 编号:2019-001 | --- | --- | --- | |----------------|-------------------------------------|----------------------------| | | | | | | | 特定对象调研 分析师会议 | | | 媒体采访 | 业绩说明会 | | 投资者关系活动 | 新闻发布会 路演活动 | | | 类别 | 现场参观 | | | | 其他 | (请文字说明其他活动内容) | | | 华创证券 | 卫喆、王卓星 | | 投资者单位名称 | 中信证券 陈卓 | | | 及人员姓名 | 民生证券 王一川 方正富邦基金 李卓建 | | | 时间 | 2019 年 8 月 16 日 | | | 地点 | 公司二楼会议室 | | | 上市公司 | 副总经理兼董事会秘书 | 陈英 | | 接待人员姓名 | 证券事务代表 骆星烁 | | 1 | --- | --- | |----------------|------------------- ...
苏试试验(300416) - 苏试试验调研活动信息
2022-12-03 08:54
编号:2020-001 证券代码:300416 证券简称:苏试试验 债券代码:123060 债券简称:苏试转债 苏州苏试试验集团股份有限公司 投资者关系活动记录表 | --- | --- | --- | |---------------------------|--------------------------------------|----------------------------| | | | | | | 特定对象调研 | 分析师会议 | | | 媒体采访 业绩说明会 | | | 投资者关系活 | 新闻发布会 路演活动 | | | 动类别 | 现场参观 | | | | 其他 | (请文字说明其他活动内容) | | | 万家基金 董一平 | | | | 民生证券 杨任重 | | | 投资者单位名 称及人员姓名 | 太平洋证券 浦银安盛基金 | 杨俊龙、陶贻功 柯聪伟 | | | 兴证全球基金 张睿 国海富兰克林基金 | 刘怡敏 | | 时间 | 2020 年 11 月 5 日 | | | 地点 | 公司二楼会议室 | | | 上市公司 | 副总经理兼董事会秘书 陈英 | | | | 证券事务代表 ...
苏试试验(300416) - 苏试试验调研活动信息
2022-11-23 07:02
证券代码:300416 证券简称:苏试试验 债券代码:123060 债券简称:苏试转债 苏州苏试试验集团股份有限公司 投资者关系活动记录表 编号:2021-001 | --- | --- | --- | |--------------|-----------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------| | | | | | | 特定对象调研 | 分析师会议 | | | | 媒体采访 业绩说明会 | | 投资者关系活 | 新闻发布会 路演活动 | | | 动类别 | 现场参观 | | | | 其他 | (请文字说明其他活动内容) | | | 国元证券 | 王舒磊 洪赢投资 刘高 | | | 苏州投资 | 陈道西 贵山私募 贺文飞 | | | 美兰创投 陈蒙蒙 | 御升资产 朱春华 | | | | | | | 天萃宝资产 徐樱 ...
苏试试验(300416) - 2022 Q3 - 季度财报
2022-10-25 16:00
Financial Performance - The company's revenue for Q3 2022 reached ¥461,052,405.39, representing a 20.68% increase year-over-year[7] - Net profit attributable to shareholders for Q3 2022 was ¥72,487,323.05, a 45.13% increase compared to the same period last year[7] - The net profit after deducting non-recurring gains and losses was ¥66,163,410.84, up 47.38% year-over-year[7] - The company reported a basic earnings per share of ¥0.1960 for Q3 2022, which is a 45.14% increase year-over-year[7] - The company reported a 35.95% increase in net profit attributable to shareholders for the year-to-date period, totaling ¥178,718,924.34, driven by growth in environmental and reliability testing services[14] - Net profit rose to ¥205,560,651.59, compared to ¥151,279,298.81 in the previous period, marking an increase of approximately 36%[51] - The total profit amounted to ¥233,116,740.30, up from ¥175,474,401.76, reflecting a growth of around 32.9%[51] - Basic and diluted earnings per share were both ¥0.4831, compared to ¥0.3554 in the same period last year, indicating an increase of approximately 36%[54] Assets and Liabilities - The total assets at the end of Q3 2022 amounted to ¥3,978,849,770.69, reflecting a 5.50% increase from the end of the previous year[7] - The company's equity attributable to shareholders rose to ¥1,876,703,690.66, an increase of 9.5% from ¥1,713,444,454.91 year-over-year[46] - The total liabilities amounted to ¥1,927,496,604.23, slightly up from ¥1,922,040,675.99 in the previous year[46] - Non-current assets totaled ¥1,607,792,591.76, reflecting a growth of 3.9% compared to ¥1,554,374,637.04 in the previous year[43] - Total assets reached ¥3,978,849,770.69, up 5.5% from ¥3,771,306,061.50 year-over-year[43] Cash Flow - The cash flow from operating activities for the year-to-date period reached ¥114,613,297.78, showing a 50.88% increase compared to the same period last year[7] - Operating cash inflow totaled ¥1,164,238,402.17, slightly up from ¥1,149,669,865.34, showing a growth of about 1.3%[55] - Net cash flow from operating activities was $114.61 million, an increase from $75.96 million year-over-year[58] - Total cash outflow from operating activities amounted to $1.05 billion, slightly down from $1.07 billion in the previous year[58] - Cash inflow from financing activities totaled $494.87 million, a decrease from $503.01 million year-over-year[58] - The ending balance of cash and cash equivalents was $796.33 million, up from $312.55 million year-over-year[58] Shareholder Information - The total number of common shareholders at the end of the reporting period is 9,076[15] - The largest shareholder, Suzhou Testing Instrument General Factory, holds 35.71% of shares, totaling 132,124,200 shares[15] - The second-largest shareholder, China Merchants Bank Co., Ltd. - Penghua New Industry Mixed Securities Investment Fund, holds 2.05% of shares, totaling 7,575,681 shares[18] - The company has a total of 10 major shareholders, with the smallest holding 0.74% of shares, totaling 2,741,600 shares[18] - The report indicates that there are no related party relationships among the top 10 shareholders[18] Operational Metrics - The company experienced a 45.93% increase in accounts receivable, totaling ¥838,923,153.98, due to revenue growth and delayed collections[11] - Inventory increased to ¥443,609,020.90, a rise of 25.7% from ¥353,024,923.73 year-over-year[43] - Accounts receivable increased to ¥838,923,153.98 from ¥574,865,610.76, indicating a significant rise in outstanding payments[40] - The company reported a decrease in prepayments to ¥116,578,855.42 from ¥100,327,476.07[40] Investment and R&D - The company invested significantly in laboratory construction, with construction in progress increasing by 51.85% to ¥203,564,346.06[11] - R&D expenses increased to ¥91,480,338.88 from ¥74,200,893.12, representing a growth of approximately 23.3% year-over-year[51] Future Outlook - The report does not indicate any new strategies or market expansions for the upcoming period[27] - Future outlook includes plans for market expansion and potential new product development initiatives[48]